Whether a $500 million damages award against Genentech stands will likely come down to whether the California Supreme Court interprets a 32-year-old contract as establishing a fiduciary relationship between the biotech giant and a research center. That issue was the focus of Tuesday's oral argument in the long-awaited case, as the court's justices attempted to nail down exactly what constitutes a fiduciary relationship in a patent contract. The seven judges failed to give any signs about who would prevail.
Calif. High Court's Leanings Hard to See in City of Hope Patent Case
February 6, 2008